Market Closed -
OTC Markets
03:25:44 2024-04-26 pm EDT
5-day change
1st Jan Change
0.3525
USD
+2.78%
+3.80%
+109.82%
BioLargo, Inc. cancelled the transaction announced on December 13, 2022
As of December 13, 2023, BioLargo, Inc., cancelled the transaction.
Transcript : BioLargo, Inc., Q4 2023 Earnings Call, Apr 02, 2024
Apr. 02
BioLargo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Apr. 01
CI
Biolargo Equipment Solutions & Technologies, Inc Appoints Sally Gutierrez to the Board of Directors
Feb. 12
CI
BioLargo, Inc. Launches Water Equipment Subsidiary to Capitalize on Opportunities in PFAS and Water Treatment
Jan. 29
CI
BioLargo, Inc. announced that it has received $0.815 million in funding
Jan. 22
CI
BioLargo's PFAS Removal Technology Lands Drinking Water Treatment Project in New Jersey
Dec. 20
CI
BioLargo, Inc. cancelled the transaction announced on December 13, 2022
Dec. 12
CI
Transcript : BioLargo, Inc., Q3 2023 Earnings Call, Nov 20, 2023
Nov. 20
BioLargo, Inc. announced that it expects to receive $0.815 million in funding
Nov. 16
CI
BioLargo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 14
CI
Transcript : BioLargo, Inc., Q2 2023 Earnings Call, Aug 16, 2023
23-08-16
BioLargo, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-14
CI
Transcript : BioLargo, Inc., Q1 2023 Earnings Call, May 18, 2023
23-05-18
BioLargo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-17
CI
Transcript : BioLargo, Inc., 2022 Earnings Call, Apr 03, 2023
23-04-03
BioLargo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
23-03-31
CI
BioLargo, Inc. Auditor Raises 'Going Concern' Doubt
23-03-30
CI
Biolargo, Inc. Announces Revenue Results for the Year 2022
23-01-09
CI
BioLargo, Inc. announced that it expects to receive $10 million in funding from Lincoln Park Capital, LLC
22-12-12
CI
Biolargo, Inc. Announces That the Pooph™ Pet Odor Control Product Line Is Now Available At Select Walmart Stores
22-11-22
CI
Transcript : BioLargo, Inc., 2022 Earnings Call, Nov 16, 2022
22-11-16
BioLargo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
22-11-14
CI
Biolargo, Inc. Announces Board and Committee Changes
22-11-03
CI
BioLargo Reports Preliminary Revenue Results for the Third Quarter of 2022
22-10-26
CI
Biolargo Secures Product Recovery Management as Channel Partner and Contract Manufacturer for Biolargo’s Water Treatment Technologies
22-10-06
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The Company invents, develops, and commercializes platform technologies to solve challenging environmental problems like polyfluoroalkyl substances (PFAS) contamination, advanced water and wastewater treatment, industrial odor control, air quality control, infection control, and myriad environmental remediation challenges. The Companyâs segments include ONM Environmental, which manufactures and sells its odor and VOC control products and services, including its flagship product, CupriDyne Clean; BLEST, which provides professional engineering services supporting its internal business units; Clyra Medical, which develops and sells medical products based on its technology; BioLargo Canada, which is primary engaged in research and development activities; and Corporate Operations, which support the operating segments with legal, accounting, human resources, and other services.
More about the company
Last Close Price
0.3525
USD
Average target price
0.35
USD
Spread / Average Target
-0.71%
Consensus
1st Jan change
Capi.
+109.82% 104M +5.14% 103B -5.63% 63.04B +39.52% 39.06B +12.91% 37.58B +7.41% 33.24B +6.85% 19.22B +12.86% 16.83B +7.73% 15.03B +16.93% 14.96B
Other Commodity Chemicals
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
BIOLARGO, INC. 
